Skip to content
10-Q

Quarterly Report

DERMA SCIENCES, INC.

0001144204-15-063424

← back to feed
Filed
Nov 6, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 5, 2015 25.81M sh
Short Term Investments Q3 2015 · Sep 30, 2015 $35M
Short Term Investments Q3 2015 · Dec 31, 2014 $56M
Stockholders Equity Q3 2015 · Sep 30, 2015 $104.52M
Stockholders Equity Q3 2015 · Dec 31, 2014 $125.56M
Current Liabilities Q3 2015 · Sep 30, 2015 $10.75M
Current Liabilities Q3 2015 · Dec 31, 2014 $11.51M
Total Liabilities Q3 2015 · Sep 30, 2015 $13.35M
Total Liabilities Q3 2015 · Dec 31, 2014 $13.73M
Current Assets Q3 2015 · Sep 30, 2015 $78.05M
Current Assets Q3 2015 · Dec 31, 2014 $100.84M
Total Assets Q3 2015 · Sep 30, 2015 $117.87M
Total Assets Q3 2015 · Dec 31, 2014 $139.3M
Sga Expense Q3 2015 · Sep 30, 2015 $12.78M
Sga Expense Q3 2015 · Sep 30, 2015 $39.78M
Sga Expense Q3 2015 · Sep 30, 2014 $13.01M
Sga Expense Q3 2015 · Sep 30, 2014 $38.69M
Capex Q3 2015 · Sep 30, 2014 $1.11M
Cash And Equivalents Q3 2015 · Sep 30, 2014 $43.26M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $6.5M
Rd Expense Q3 2015 · Sep 30, 2014 $4.44M
Rd Expense Q3 2015 · Sep 30, 2014 $12.99M
Net Income Q3 2015 · Sep 30, 2014 −$11.25M
Net Income Q3 2015 · Sep 30, 2014 −$30.2M
Operating Income Q3 2015 · Sep 30, 2014 −$11.1M
Operating Income Q3 2015 · Sep 30, 2014 −$30.57M
Gross Profit Q3 2015 · Sep 30, 2014 $6.36M
Gross Profit Q3 2015 · Sep 30, 2014 $21.12M
Cost Of Revenue Q3 2015 · Sep 30, 2014 $13.81M
Cost Of Revenue Q3 2015 · Sep 30, 2014 $39.76M